About the journal
Une publication de la Société française de radiothérapie oncologique (SFRO)
Articles in French (mainly) and English, Abstracts in French and English
Cancer/radiothérapie se veut d'abord et avant tout un organe francophone de publication des travaux de recherche en radiothérapie. La revue a pour …
$2190
Article publishing charge
for open access
11 days
Time to first decision
49 days
Review time
34 days
Submission to acceptance
Editor-in-chief
View full editorial boardArticles
EditorialNo accessApril 2024
https://doi.org/10.1016/j.canrad.2024.02.001
Research articleAbstract onlyApril 2024
https://doi.org/10.1016/j.canrad.2023.06.031
Research articleAbstract onlyApril 2024
https://doi.org/10.1016/j.canrad.2023.06.032
Research articleAbstract onlyApril 2024
https://doi.org/10.1016/j.canrad.2023.07.014
Research articleAbstract onlyApril 2024
https://doi.org/10.1016/j.canrad.2023.07.017
Research articleAbstract onlyApril 2024
https://doi.org/10.1016/j.canrad.2023.08.009
Research articleAbstract onlyApril 2024
https://doi.org/10.1016/j.canrad.2023.08.010
Research articleAbstract onlyApril 2024
https://doi.org/10.1016/j.canrad.2023.11.001
More from Cancer/Radiothérapie
Special issues and article collections
Indication of radiotherapy for de novo metastatic cancer. The « Recommendations » Commission first issue - Coordonné par Igor Latorzeff et David Azria
Edited by MD Igor Latorzeff MD, MD, PhD David Azria MD, PhD
February 2024
RecoRad™
February–April 2022
Print ISSN: 1278-3218
Online ISSN: 1769-6658
Copyright © 2024 Soci�t� fran�aise de radioth�rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.